Skip to main content
Premium Trial:

Request an Annual Quote

Roche Receives FDA Emergency Use Authorization for Cobas Monkeypox Test

NEW YORK – The US Food and Drug Administration said on Tuesday that it has granted Emergency Use Authorization for Roche's molecular monkeypox test. 

The RT-PCR test, which qualitatively detects DNA from monkeypox virus in human lesion swab specimens, runs on the Cobas 6800/8800 systems. It is intended for use at moderate- and high-complexity labs and authorized for use in people suspected of monkeypox virus infection by their healthcare provider, the FDA said in a statement. 

The agency began issuing EUAs for monkeypox tests in September after the US Department of Health and Human Services declared a public health emergency for the virus in August. Quest Diagnostics obtained EUA for its monkeypox test in September, while Abbott received EUA for its test last month. 

The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.